(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPÓSITO DE (HIDR)ÓXIDO DE METAL, E, COMPOSIÇÃO FARMACÊUTICA

Em ExigênciaInvention PatentPCT · KR2021013215

Application data

Number

112022016506

Type

Invention Patent

Filing

09/28/2021

Publication

10/11/2022

PCT

KR2021013215

Progress at the INPI

Technical opinion to answer
  1. Filing09/28/21
  2. Publication10/11/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

AlertaMarcas

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 11/04/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CNPHARM CO., LTD.

KR

WEBIOTREE CO., LTD

KR

Inventors

G. J. (pessoa física)

KR

H. K. (pessoa física)

KR

K. K. (pessoa física)

KR

Technical data

Priority claims

KR

PCT/KR2021/005208 · 04/23/2021

US

63/084,423 · 09/28/2020

US

63/085,605 · 09/30/2020

US

63/125,122 · 12/14/2020

US

63/126,717 · 12/17/2020

US

63/150,235 · 02/17/2021

US

63/153,206 · 02/24/2021

US

63/157,181 · 03/05/2021

Abstract

COMPÓSITO DE (HIDR)ÓXIDO DE METAL, E, COMPOSIÇÃO FARMACÊUTICA. A presente invenção refere-se a um compósito de (hidr)óxido de metal compreendendo um fármaco pouco solúvel, um método para fabricar o mesmo e uma composição farmacêutica compreendendo o mesmo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

11/04/2025

RPI 2861

8.7

11/12/2024

RPI 2810

Arquivamento por falta de pagamento

#8.6

Referente à 3ª anuidade.

10/15/2024

RPI 2806

Notificação de entrada na fase nacional - PCT

#1.3

10/11/2022

RPI 2701

Alteração de dados cadastrais

#1.1

08/30/2022

RPI 2695

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.